Ownership history in Stonepine Capital Management, LLC · 19 quarters on record
This page tracks every 13F SEC filing in which Stonepine Capital Management, LLC reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 740,000 | +1,000 | +0.1% | 9.85% | $13.5M | $18.24 |
| 2025 Q3 | REDUCED | 739,000 | -11,000 | -1.5% | 8.81% | $10.83B | $14.66 |
| 2025 Q2 | REDUCED | 750,000 | -60,000 | -7.4% | 13.40% | $13.7M | $18.21 |
| 2025 Q1 | REDUCED | 810,000 | -431,032 | -34.7% | 0.02% | $24.3M | $19.84 |
| 2024 Q4 | REDUCED | 1,241,032 | -628,968 | -33.6% | 17.18% | $21.3M | $17.15 |
| 2024 Q3 | UNCHANGED | 1,870,000 | — | 0% | 23.62% | $37.4M | $19.99 |
| 2024 Q2 | REDUCED | 1,870,000 | -1,556,882 | -45.4% | 19.20% | $20.9M | $11.18 |
| 2024 Q1 | REDUCED | 3,426,882 | -5,795,735 | -62.8% | 17.94% | $22.62B | $6.60 |
| 2023 Q4 | ADDED | 9,222,617 | +118,342 | +1.3% | 18.03% | $41.7M | $4.52 |
| 2023 Q3 | ADDED | 9,104,275 | +310,954 | +3.5% | 10.83% | $32.59B | $3.58 |
As of 2025 Q4 — sorted by position size